Best Kinase Inhibitor for carcinoma, renal cell
7 Kinase Inhibitor drugs indicated for carcinoma, renal cell, ranked by our independent rating. The current highest-rated is votrient. Compare them with all treatments for carcinoma, renal cell or the full Kinase Inhibitor class. Not medical advice — always consult a professional.
Top kinase inhibitor for carcinoma, renal cell: 1. Votrient · 2. Lenvima · 3. Nexavar
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Votrient | 68/100 | Prescription | — | View → |
| 2 | Lenvima | Not yet rated | Prescription | — | View → |
| 3 | Nexavar | Not yet rated | Prescription |
Full ranking · 7 drugs
Frequently asked
- What is the best kinase inhibitor for carcinoma, renal cell?
- By our independent rating, votrient currently ranks highest among Kinase Inhibitor drugs used for carcinoma, renal cell. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which kinase inhibitor drugs treat carcinoma, renal cell?
- pharmaranks lists 7 Kinase Inhibitor products indicated for carcinoma, renal cell, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.